Trimethoprim-sulphamethoxazole in enteric fevers.
Clinical improvement was rapid in all 13 patients with enteric fever and one with Brucella abortus infection treated with trimethoprim-sulphamethoxazole. There were no side-effects of the treatment and it was found easy to administer to toxic and delirious patients.
D000293:Adolescent; D001769:Blood / Q000382:microbiology; D002003:Brucella abortus / Q000302:isolation & purification; D002006:Brucellosis / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011743:Pyrimidines / Q000627:therapeutic use*; D012482:Salmonella paratyphi A / Q000302:isolation & purification; D012485:Salmonella typhi / Q000302:isolation & purification; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014435:Typhoid Fever / Q000188:drug therapy*
D005493:Folic Acid Antagonists; D011743:Pyrimidines; D013420:Sulfamethoxazole